Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized phase II study designed to evaluate the effect of local consolidative
radiation therapy (LCT) to all sites of oligoprogressive disease in patients with metastatic
non-small cell lung carcinoma who have progressed through first line systemic therapy
containing an immune checkpoint inhibitor (ICI).